ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 711613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 711613; 2) Community: the network communities that were significantly associated with the response to NSC 711613; 3) Molecule: the relationships between components within communities and NSC 711613; 4) MDR: the compounds that were significantly associated with the NSC 711613.

NSC Compound Enrichment Correlation
NSC 268251 4,6-DIDEOXY-4-[[[(14-METHYL-1-OXOPENTADECYL)AMINO]ACETYL]AMINO]-N-1H-PURIN-6-YL-.BETA.-L-GLUCOPYRANOSYLAMINE 0.0252510646170347 -0.13584866
NSC 269719 Estr-4-en-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (17.beta.)- 0.0252510646170347 0.076276218
NSC 49460 Null 0.0252510646170347 0.24033774
NSC 52245 17-Methylestradiol 0.0252510646170347 0.47123082
NSC 57187 Null 0.0252510646170347 0.26600351
NSC 620674 Null 0.0252510646170347 -0.14532329
NSC 627771 4-Aza-2'-phenyl-5.alpha.-cholestano[3,2-c]pyrazole 0.0252510646170347 0.10842034
NSC 630703 Acridomide 0.0252510646170347 0.22462041
NSC 665001 Null 0.0252510646170347 0.20321195
NSC 666288 Null 0.0252510646170347 -0.08472087
Total:50  Current:27    [First] [Prev] [Next] [Last]